FC
Fred B Craves (Director) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $5.0M of MDGL (15,195 sh across 11 lots, as filed), executed Mar 12 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.1M
shares × price, as filed
Last traded
Mar 13 2025
Filed Mar 14 2025
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$5.0M15,195 sh across 11 lots
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $1.1M
3,600 sh across 2 lots
Exec Dec 3 2024
Filed Dec 5 2024 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $1.2M
3,400 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET